8-iso Prostaglandin E2

Modify Date: 2024-01-11 18:55:06

8-iso Prostaglandin E2 Structure
8-iso Prostaglandin E2 structure
Common Name 8-iso Prostaglandin E2
CAS Number 27415-25-4 Molecular Weight 352.465
Density 1.1±0.1 g/cm3 Boiling Point 530.1±50.0 °C at 760 mmHg
Molecular Formula C20H32O5 Melting Point N/A
MSDS N/A Flash Point 288.5±26.6 °C

 Use of 8-iso Prostaglandin E2


8-Isoprostaglandin E2 (iPE2-III) is a member of the isoprostane class of prostanoids. 8-Isoprostaglandin E2 acts at the receptor for thromboxane A2 (the TP) in vivo to induce vasoconstriction and platelet aggregation. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway[1][2].

 Names

Name 8-iso Prostaglandin E2
Synonym More Synonyms

 8-iso Prostaglandin E2 Biological Activity

Description 8-Isoprostaglandin E2 (iPE2-III) is a member of the isoprostane class of prostanoids. 8-Isoprostaglandin E2 acts at the receptor for thromboxane A2 (the TP) in vivo to induce vasoconstriction and platelet aggregation. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway[1][2].
Related Catalog
References

[1]. Wilson SJ, et al. Heterodimerization of the alpha and beta isoforms of the human thromboxane receptor enhances isoprostane signaling. Biochem Biophys Res Commun. 2007;352(2):397-403.

[2]. Tintut Y, et al. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway. J Biol Chem. 2002;277(16):14221-14226.

 Chemical & Physical Properties

Density 1.1±0.1 g/cm3
Boiling Point 530.1±50.0 °C at 760 mmHg
Molecular Formula C20H32O5
Molecular Weight 352.465
Flash Point 288.5±26.6 °C
Exact Mass 352.224976
PSA 94.83000
LogP 1.88
Vapour Pressure 0.0±3.2 mmHg at 25°C
Index of Refraction 1.561

 Synonyms

l-7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid
(5E,13E)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
5-Heptenoic acid, 7-[3-hydroxy-2- (3-hydroxy-1-octenyl)-5-oxocyclopentyl]-
(5Z,8β,11α,12ξ,13E,15S)-11,15-Dihydroxy-9-oxoprosta-5,13-dien-1-oic acid
5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-
7-(3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-5-heptenoic acid
(5E)-7-{3-Hydroxy-2-[(1E)-3-hydroxy-1-octen-1-yl]-5-oxocyclopentyl}-5-heptenoic acid
Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,8β,11α,12ξ,13E,15S)-
5-Heptenoic acid, 7-(3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl)-, l-
Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5E,13E)-
7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid